Psoriament®

Therapeutic Area:
Generic Name:

Calcipotriol

Dosage Form:

Topical ointment 0.005%

Drug Dose

Therapeutic Indications:

If the cells in your skin grow too much you may get psoriasis. Psoriasis is a condition where your skin develops raised red patches and silver coloured scaly patches. The scaly patches are dead cells that would normally fall off your skin without you noticing. Psoriament® works by reducing the number of cells your skin makes. This means your skin symptoms will reduce too.

Mechanism of Action:

Psoriament® belongs to a group of medicines called anti-psoriatics. It is a type of vitamin D. Vitamin D controls how the cells in your skin grow.

Method of Administration:

Adults:

Your dose will depend on how bad your psoriasis is. Your doctor will prescribe the dose that is right for you. Use the medicine once or twice each day. Follow the advice of your doctor. Do not use more than 100 grams each week.

Children and adolescents:

The dose will depend on how bad the psoriasis is. Your doctor will prescribe the dose that is right for your child.

  • Children over 12 years old:

Use the medicine twice each day. Do not use more than 75 grams each week.

  • Children between 6 and 12 years old:

Use the medicine twice each day. Do not use more than 50 grams each week.

  • Children under 6 years old:

Do not use on children under 6 years of age

Notes

Contraindications:

Psoriament® is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. It should not be used by patients with demonstrated hypercalcemia or evidence of vitamin D toxicity.

Interactions:

No information provided.

Pregnancy and Lactation:

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. If your doctor has agreed that you can breast-feed, do not apply Psoriament® to the breast area.

Warning and Precaution:

Use of Calcipotriol may cause irritation of lesions and surrounding uninvolved skin. If irritation develops, Calcipotriol should be discontinued.

Transient, rapidly reversible elevation of serum calcium has occurred with use of Calcipotriol. If elevation in serum calcium outside the normal range should occur, discontinue treatment until normal calcium levels are restored.

Adverse Reactions:

Burning, itching and skin irritation, which occurred in approximately 10-15% of patients. Erythema, dry skin, peeling, rash, dermatitis, worsening of psoriasis including development of facial/scalp psoriasis were reported in 1 to 10% of patients. Other experiences reported in less than 1% of patients included skin atrophy, hyperpigmentation, hypercalcemia, and folliculitis.

Storage:

Store below 30 and protect from light and moisture.